Activation of p107 by Fibroblast Growth Factor, Which Is Essential for Chondrocyte Cell Cycle Exit, Is Mediated by the Protein Phosphatase 2A/B55α Holoenzyme

REFERENCES

• Dick FA. 2007. Structure-function analysis of the retinoblastoma tumor suppressor protein—is the whole a sum of its parts? Cell Div. 2:26.
   PubMed Web of Science ®Google Scholar
• Graña X, Garriga J, Mayol X. 1998. Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth. Oncogene 17:3365–3383.
   PubMed Web of Science ®Google Scholar
• Sotillo E, Graña X. 2010. Escape from cellular quiescence, p 3–22.InEnders GH (ed),Cell cycle deregulation in cancer. Springer Publishing, New York, NY.
   Google Scholar
• Kurimchak A, Graña X. 2012. PP2A holoenzymes negatively and positively regulate cell cycle progression by dephosphorylating pocket proteins and multiple CDK substrates. Gene 499:1–7.
   PubMed Web of Science ®Google Scholar
• Sherr CJ, Roberts JM. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13:1501–1512.
   PubMed Web of Science ®Google Scholar
• Rowland BD, Bernards R. 2006. Re-evaluating cell-cycle regulation by E2Fs. Cell 127:871–874.
   PubMed Web of Science ®Google Scholar
• Fisher RP. 2012. The CDK network: linking cycles of cell division and gene expression. Genes Cancer 3:731–738.
   PubMedGoogle Scholar
• Kurimchak A, Graña X. 2012. PP2A counterbalances phosphorylation of pRB and mitotic proteins by multiple CDKs: potential implications for PP2A disruption in cancer. Genes Cancer 3:739–748.
   PubMedGoogle Scholar
• Enders GH. 2012. Mammalian interphase cdks: dispensable master regulators of the cell cycle. Genes Cancer 3:614–618.
   PubMedGoogle Scholar
• MacDonald J, Dick FA. 2012. Posttranslational modifications of the retinoblastoma tumor suppressor protein as determinants of function. Genes Cancer 3:619–633.
   PubMedGoogle Scholar
• Calbó J, Parreño M, Sotillo E, Yong T, Mazo A, Garriga J, Graña X. 2002. G1 cyclin/CDK coordinated phosphorylation of endogenous pocket proteins differentially regulates their interactions with E2F4 and E2F1 and gene expression. J. Biol. Chem. 277:50263–50274.
   PubMed Web of Science ®Google Scholar
• Graña X. 2008. Downregulation of the phosphatase nuclear targeting subunit (PNUTS) triggers pRB dephosphorylation and apoptosis in pRB positive tumor cell lines. Cancer Biol. Ther. 7:842–844.
   PubMed Web of Science ®Google Scholar
• Kolupaeva V, Janssens V. 2013. PP1 and PP2A phosphatases—cooperating partners in modulating retinoblastoma protein activation. FEBS J. 280:627–643.
   PubMed Web of Science ®Google Scholar
• Ludlow JW, Glendening CL, Livingston DM, DeCarprio JA. 1993. Specific enzymatic dephosphorylation of the retinoblastoma protein. Mol. Cell. Biol. 13:367–372.
   PubMed Web of Science ®Google Scholar
• Durfee T, Becherer K, Chen PL, Yeh SH, Yang Y, Kilburn AE, Lee WH, Elledge SJ. 1993. The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. Genes Dev. 7:555–569.
   PubMed Web of Science ®Google Scholar
• Hirschi A, Cecchini M, Steinhardt RC, Schamber MR, Dick FA, Rubin SM. 2010. An overlapping kinase and phosphatase docking site regulates activity of the retinoblastoma protein. Nat. Struct. Mol. Biol. 17:1051–1057.
   PubMed Web of Science ®Google Scholar
• Garriga J, Jayaraman AL, Limon A, Jayadeva G, Sotillo E, Truongcao M, Patsialou A, Wadzinski BE, Graña X. 2004. A dynamic equilibrium between CDKs and PP2A modulates phosphorylation of pRB, p107 and p130. Cell Cycle 3:1320–1330.
   PubMed Web of Science ®Google Scholar
• Virshup DM, Shenolikar S. 2009. From promiscuity to precision: protein phosphatases get a makeover. Mol. Cell 33:537–545.
   PubMed Web of Science ®Google Scholar
• Eichhorn PJ, Creyghton MP, Bernards R. 2009. Protein phosphatase 2A regulatory subunits and cancer. Biochim. Biophys. Acta 1795:1–15.
   PubMed Web of Science ®Google Scholar
• Jayadeva G, Kurimchak A, Garriga J, Sotillo E, Davis AJ, Haines DS, Mumby M, Graña X. 2010. B55alpha PP2A holoenzymes modulate the phosphorylation status of the retinoblastoma-related protein p107 and its activation. J. Biol. Chem. 285:29863–29873.
   PubMed Web of Science ®Google Scholar
• Magenta A, Fasanaro P, Romani S, Di Stefano V, Capogrossi MC, Martelli F. 2008. Protein phosphatase 2A subunit PR70 interacts with pRb and mediates its dephosphorylation. Mol. Cell. Biol. 28:873–882.
   PubMed Web of Science ®Google Scholar
• Voorhoeve PM, Watson RJ, Farlie PG, Bernards R, Lam EW. 1999. Rapid dephosphorylation of p107 following UV irradiation. Oncogene 18:679–688.
   PubMedGoogle Scholar
• Vuocolo SC, Purev E, Zhang D, Bartek J, Hansen K, Soprano DR, Soprano KJ. 2003. Protein phosphatase 2A associates with Rb2/p130 and mediates retinoic acid-induced growth suppression of ovarian carcinoma cells. J. Biol. Chem. 278:41881–41889.
   PubMed Web of Science ®Google Scholar
• Dailey L, Laplantine E, Priore R, Basilico C. 2003. A network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation. J. Cell Biol. 161:1053–1066.
   PubMed Web of Science ®Google Scholar
• Kolupaeva V, Laplantine E, Basilico C. 2008. PP2A-mediated dephosphorylation of p107 plays a critical role in chondrocyte cell cycle arrest by FGF. PLoS One 3:e3447. doi:10.1371/journal.pone.0003447.
   PubMed Web of Science ®Google Scholar
• Cobrinik D, Lee MH, Hannon G, Mulligan G, Bronson RT, Dyson N, Harlow E, Beach D, Weinberg RA, Jacks T. 1996. Shared role of the pRb-related p130 and p107 proteins in limb development. Genes Dev. 10:1633–1644.
   PubMed Web of Science ®Google Scholar
• Ornitz DM, Marie PJ. 2002. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev. 16:1446–1465.
   PubMed Web of Science ®Google Scholar
• Wu S, Morrison A, Sun H, De Luca F. 2011. Nuclear factor-κB (NF-κB) p65 interacts with Stat5b in growth plate chondrocytes and mediates the effects of growth hormone on chondrogenesis and on the expression of insulin-like growth factor-1 and bone morphogenetic protein-2. J. Biol. Chem. 286:24726–24734.
   PubMed Web of Science ®Google Scholar
• Haines DS, Lee JE, Beauparlant SL, Kyle DB, den Besten W, Sweredoski MJ, Graham RLJ, Hess S, Deshaies RJ. 2012. Protein interaction profiling of the p97 adaptor UBXD1 uncovers a role for the complex in ERGIC-53 trafficking. Mol. Cell. Proteomics 11:M111.016444. doi:10.1074/mcp.M111.016444.
   PubMedGoogle Scholar
• Donner AJ, Ebmeier CC, Taatjes DJ, Espinosa JM. 2010. CDK8 is a positive regulator of transcriptional elongation within the serum response network. Nat. Struct. Mol. Biol. 17:194–201.
   PubMed Web of Science ®Google Scholar
• Keskin H, Garriga J, Georlette D, Graña X. 2012. Complex effects of flavopiridol on the expression of primary response genes. Cell Div. 7:11.
   PubMedGoogle Scholar
• Krejci P, Bryja V, Pachernik J, Hampl A, Pogue R, Mekikian P, Wilcox WR. 2004. FGF2 inhibits proliferation and alters the cartilage-like phenotype of RCS cells. Exp. Cell Res. 297:152–164.
   PubMed Web of Science ®Google Scholar
• Sahni M, Ambrosetti DC, Mansukhani A, Gertner R, Levy D, Basilico C. 1999. FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. Genes Dev. 13:1361–1366.
   PubMed Web of Science ®Google Scholar
• Aikawa T, Segre GV, Lee K. 2001. Fibroblast growth factor inhibits chondrocytic growth through induction of p21 and subsequent inactivation of cyclin E-Cdk2. J. Biol. Chem. 276:29347–29352.
   Google Scholar
• Rozenblatt-Rosen O, Mosonego-Ornan E, Sadot E, Madar-Shapiro L, Sheinin Y, Ginsberg D, Yayon A. 2002. Induction of chondrocyte growth arrest by FGF: transcriptional and cytoskeletal alterations. J. Cell Sci. 115:553–562.
   PubMedGoogle Scholar
• Tran T, Kolupaeva V, Basilico C. 2010. FGF inhibits the activity of the cyclin B1/CDK1 kinase to induce a transient G(2) arrest in RCS chondrocytes. Cell Cycle 9:4379–4386.
   PubMed Web of Science ®Google Scholar
• Li S, Brignole C, Marcellus R, Thirlwell S, Binda O, McQuoid MJ, Ashby D, Chan H, Zhang Z, Miron MJ, Pallas DC, Branton PE. 2009. The adenovirus E4orf4 protein induces G2/M arrest and cell death by blocking protein phosphatase 2A activity regulated by the B55 subunit. J. Virol. 83:8340–8352.
   PubMedGoogle Scholar
• Litovchick L, Sadasivam S, Florens L, Zhu X, Swanson SK, Velmurugan S, Chen R, Washburn MP, Liu XS, DeCaprio JA. 2007. Evolutionarily conserved multisubunit RBL2/p130 and E2F4 protein complex represses human cell cycle-dependent genes in quiescence. Mol. Cell 26:539–551.
   PubMed Web of Science ®Google Scholar
• Mayol X, Garriga J, Graña X. 1996. G1 cyclin/Cdk-independent phosphorylation and accumulation of p130 during the transition from G1 to G0 lead to its association with E2F-4. Oncogene 13:237–246.
   PubMedGoogle Scholar
• Lorca T, Castro A. 2012. Deciphering the new role of the Greatwall/PP2A pathway in cell cycle control. Genes Cancer 3:712–720.
   PubMedGoogle Scholar
• Laplantine E, Rossi F, Sahni M, Basilico C, Cobrinik D. 2002. FGF signaling targets the pRb-related p107 and p130 proteins to induce chondrocyte growth arrest. J. Cell Biol. 158:741–750.
   PubMed Web of Science ®Google Scholar
• Yan Y, Frisen J, Lee MH, Massague J, Barbacid M. 1997. Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev. 11:973–983.
   PubMed Web of Science ®Google Scholar
• Yeh N, Miller JP, Gaur T, Capellini TD, Nikolich-Zugich J, de la Hoz C, Selleri L, Bromage TG, van Wijnen AJ, Stein GS, Lian JB, Vidal A, Koff A. 2007. Cooperation between p27 and p107 during endochondral ossification suggests a genetic pathway controlled by p27 and p130. Mol. Cell. Biol. 27:5161–5171.
   Google Scholar
• Lorca T, Castro A. 2013. The Greatwall kinase: a new pathway in the control of the cell cycle. Oncogene 32:537–543.
   PubMed Web of Science ®Google Scholar
• Castilho PV, Williams BC, Mochida S, Zhao Y, Goldberg ML. 2009. The M phase kinase Greatwall (Gwl) promotes inactivation of PP2A/B55delta, a phosphatase directed against CDK phosphosites. Mol. Biol. Cell 20:4777–4789.
   PubMed Web of Science ®Google Scholar
• Mochida S, Ikeo S, Gannon J, Hunt T. 2009. Regulated activity of PP2A-B55 delta is crucial for controlling entry into and exit from mitosis in Xenopus egg extracts. EMBO J. 28:2777–2785.
   PubMed Web of Science ®Google Scholar
• Vigneron S, Brioudes E, Burgess A, Labbe JC, Lorca T, Castro A. 2009. Greatwall maintains mitosis through regulation of PP2A. EMBO J. 28:2786–2793.
   PubMed Web of Science ®Google Scholar
• Gharbi-Ayachi A, Labbe JC, Burgess A, Vigneron S, Strub JM, Brioudes E, Van-Dorsselaer A, Castro A, Lorca T. 2010. The substrate of Greatwall kinase, Arpp19, controls mitosis by inhibiting protein phosphatase 2A. Science 330:1673–1677.
   PubMed Web of Science ®Google Scholar
• Mochida S, Maslen SL, Skehel M, Hunt T. 2010. Greatwall phosphorylates an inhibitor of protein phosphatase 2A that is essential for mitosis. Science 330:1670–1673.
   PubMed Web of Science ®Google Scholar
• Manchado E, Guillamot M, de Carcer G, Eguren M, Trickey M, Garcia-Higuera I, Moreno S, Yamano H, Canamero M, Malumbres M. 2010. Targeting mitotic exit leads to tumor regression in vivo: modulation by Cdk1, Mastl, and the PP2A/B55α,δ phosphatase. Cancer Cell 18:641–654.
   PubMed Web of Science ®Google Scholar
• Schmitz MH, Held M, Janssens V, Hutchins JR, Hudecz O, Ivanova E, Goris J, Trinkle-Mulcahy L, Lamond AI, Poser I, Hyman AA, Mechtler K, Peters JM, Gerlich DW. 2010. Live-cell imaging RNAi screen identifies PP2A-B55alpha and importin-beta1 as key mitotic exit regulators in human cells. Nat. Cell Biol. 12:886–893.
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, Garriga J, Calbo J, Yong T, Haines DS, Graña X. 2003. SKP2 associates with p130 and accelerates p130 ubiquitylation and degradation in human cells. Oncogene 22:2443–2451.
   PubMed Web of Science ®Google Scholar
• Tedesco D, Lukas J, Reed SI. 2002. The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2). Genes Dev. 16:2946–2957.
   PubMed Web of Science ®Google Scholar